Item nr | Item | N (minus articles with 1 rating)a | % agreement | N | Kappa |
---|---|---|---|---|---|
Generalisability Box (n = 866) b | c | ||||
Was the sample in which the HR-PRO instruments was evaluated adequately described? In terms of: | |||||
1d | median or mean age (with standard deviation or range)? | 733 | 86 | 865 | 0.36 |
2d | distribution of sex? | 735 | 88 | 863 | 0.38e |
3 | important disease characteristics (e.g. severity, status, duration) and description of treatment? | 746 | 80 | 862 | 0.39f |
4d | setting(s) in which the study was conducted? e.g. general population, primary care or hospital/rehabilitation care | 735 | 89 | 863 | 0.30e |
5d | countries in which the study was conducted? | 733 | 90 | 861 | 0.40e |
6d | language in which the HR-PRO instrument was evaluated? | 733 | 86 | 861 | 0.41e |
7d | Was the method used to select patients adequately described? e.g. convenience, consecutive, or random | 729 | 81 | 857 | 0.40 |
8 | Was the percentage of missing responses (response rate) acceptable? | 724 | 82 | 849 | 0.48 |